Nabriva Therapeutics PLC (NASDAQ:NBRV)

0.1897
Delayed Data
As of Jul 06
 -0.0055 / -2.93%
Today’s Change
0.17
Today|||52-Week Range
1.40
-68.33%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +954.30% increase from the last price of 0.19.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Nabriva Therapeutics PLC. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.19
Sales
$9.5M
Reporting Date
Aug 11

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.00%
 
 
 
 
 
 
Growthannually 35.96%
 
 
 
 
 
 

Sales

Growthquarterly 18.02%
 
 
 
 
 
 
Growthannually 42.95%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.